Texas A&M researchers win NIH grant to study metabolism in people with Down syndrome

A team of researchers at the Texas A&M University School of Veterinary Medicine & Biomedical Sciences (VMBS) has received a grant from the National Institutes of Health (NIH) to research metabolism in people with Down syndrome.

CureVac releases mixed interim Phase 2 data for seasonal flu vaccine

CureVac’s seasonal flu vaccine boosted antibody titers in influenza A strains but it missed the mark in influenza B in a Phase 2 trial. The

April 5, 2024

Roche’s $3 billion Alnylam deal shows drug firms are interested in long-acting heart drugs

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of

July 24, 2023

Anemia: A global health problem with wide disparities

Anemia affected nearly 2 billion people in 2021, impacting women to a greater degree than men. In a new study covering three decades of global

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.